Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptionsMarch 19, 2025Natalie Telis PhDShareCategoriesPublished ResearchHealth SystemsPopulation GenomicsResearch